FDA Expands Indication for Cerezyme (Imiglucerase) To Treat Gaucher Disease Type 3 by Madaline Spencer| Published on: Jan 28, 2026

https://checkrare.com/fda-expands-indication-for-cerezyme-imiglucerase-to-treat-gaucher-disease-type-3/ The US Food and Drug Administration (FDA) has approved the expanded indication of Cerezyme (imiglucerase) for the treatment of non-neuronal symptoms in adult and pediatric patients with Gaucher disease (GD) type 3.